Skip to main content
OTLK
NASDAQ Life Sciences

FDA Accepts Outlook Therapeutics' Resubmitted BLA for Wet AMD Drug, Sets July 29 PDUFA Date

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$1.21
Mkt Cap
$185.772M
52W Low
$0.161
52W High
$3.39
52W Position info
651% above low
Off High info
64% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

OTLK has more than doubled off its 52-week low of $0.161.

Summary

The FDA has accepted Outlook Therapeutics' resubmitted Biologics License Application (BLA) for ONS-5010/LYTENAVA™ for wet AMD, designating it a Class 1 review. This follows the company's successful appeal to the FDA in late May and the BLA resubmission on June 1. The acceptance is a crucial positive step for the company, which has recently faced significant financial challenges and dilution. A final FDA decision is now expected by the PDUFA target action date of July 29, 2026.

At the time of this announcement, OTLK was trading at $1.21 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $185.8M. The 52-week trading range was $0.16 to $3.39. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

OTLK - Latest Insights

OTLK
Sep 30, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.5989
Real-time Price: $0.434 info
Change: -$0.1649 (-28%) info
Market Cap: $106.898M info
OTLK
Sep 18, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.670776
Real-time Price: $0.434 info
Change: -$0.236776 (-35%) info
Market Cap: $106.898M info
OTLK
Aug 18, 2026, 5:29 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.6982
Real-time Price: $0.434 info
Change: -$0.2642 (-38%) info
Market Cap: $106.898M info
OTLK
Aug 17, 2026, 7:27 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.7973
Real-time Price: $0.434 info
Change: -$0.3633 (-46%) info
Market Cap: $106.898M info
OTLK
Aug 14, 2026, 7:54 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.790
Real-time Price: $0.434 info
Change: -$0.356 (-45%) info
Market Cap: $106.898M info